Chinese Journal of Evidence-Based Medicine
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Interpretation of the statistical analysis plan (SAP) extended reporting guidelines and their enlightenment for the design of early stage clinical studies of new drugs.
24:1347-1351.
2024
-
Application of the subpopulation treatment effect pattern plot (STEPP) method in clinical trials.
980-985.
2024
-
Fragility index for assessing the robustness of randomized controlled trials.
24:243-248.
2024
-
A pioneer in addressing societal challenges with evidence-informed decision-making: Global Commission on Evidence.
23:1222-1228.
2023
-
Application progress and interpretation of E-value in sensitivity analysis.
22:988-992.
2022
-
Method to draw conclusions from a network meta-analysis: A minimally contextualised framework.
21:1102-1109.
2021
-
Method to draw conclusions from a network meta-analysis: A partially contextualised framework.
21:1110-1116.
2021
-
Characteristics of the international clinical studies using objective performance criteria.
19:1308-1316.
2019
-
Promoting the rapid creation and effective use of high-quality clinical practice guidelines: MAGIC system and China initiative.
19:2-6.
2019
-
Research on integrated traditional Chinese medicine and western medicine for geriatrics: Progress and reflections.
18:1191-1197.
2018
-
Background research for the decision support tool of evidence-based evaluation for essential medicines: 1. overview of quality assessment tools for systematic review of randomized controlled trials.
15:723-729.
2015
-
Guidelines 2.0: Systematic development of a comprehensive checklist for a successful guideline enterprise△.
14:1135-1149.
2014
-
Guidance for evidence-informed policies about health systems: Linking guidance development to policy development.
14:783-788.
2014
-
Guidance for evidence-informed policies about health systems: Rationale for and challenges of guidance development.
14:777-782.
2014
-
Guidance for evidence-informed policies about health systems: assessing how much confidence to place in the research evidence.
14:789-794.
2014
-
Performance evaluation of primary healthcare system reform in Xinjin County, Chengdu City. VIII: Evaluation of the essential public health services from 2009 to 2011.
14:385-393.
2014
-
Performance evaluation of primary healthcare system reform in Xinjin County, Chengdu City: VII. Use of essential medicines in primary healthcare system from 2009 to 2011.
14:380-384.
2014
-
Performance evaluation of primary healthcare system reform in Xinjin county, Chengdu City: III. Survey on human resources of village doctors for rural integrated management between township hospitals and village clinics.
14:134-139.
2014
-
Performance evaluation of primary healthcare system reform in Xinjin county, Chengdu city: I. Total performance.
14:2-6.
2014
-
Performance evaluation of primary healthcare system reform in Xinjin county, Chengdu city: II. Survey on human resources in primary healthcare institutions.
14:7-15.
2014
-
Performance evaluation of primary healthcare system reform in Xinjin county, Chengdu city: IV. survey on out-patient and in-patient disease composition of different levels of hospitals.
14:140-146.
2014
-
Performance evaluation of primary healthcare system reform in Xinjin county, Chengdu city: V. evaluation on primary healthcare performance in Xinjin county from 2009 to 2010.
14:249-254.
2014
-
Performance evaluation of primary healthcare system reform in Xinjin county, Chengdu city: VI. drug utilization in healthcare institutions of Xinjing county in 2010.
14:255-259.
2014
-
Can China master the guideline challenge?.
13:621-623.
2013
-
A status survey on disease constitution in Xiaokunshan township health center, Songjiang district of Shanghai city from 2008 to 2010.
12:142-147.
2012
-
A status survey on disease constitution in yaqian township health center, Xiaoshan district of Zhejiang province from 2008 to 2010.
12:156-160.
2012
-
A status survey on inpatient disease constitution in Jili Community Health Service Center, Liuyang City of Hunan Province, from 2008 to 2010.
12:25-30.
2012
-
A status survey on inpatient diseases constitution and hospitalization expenses in Luxi township health center, Yongxin county of Jiangxi Province, in 2010.
12:16-24.
2012
-
A survey on inpatient disease constitution and hospitalization expenses in Songqiao central township health center of Gaoyou city, Jiangsu province in 2010.
12:123-124.
2012
-
Analysis on expenses of top 15 single diseases among inpatients in Jili Community Health Service Center in Liuyang City of Hunan Province.
12:398-405.
2012
-
Analysis on therapeutic effects and influencing factors of focused ultrasound in 7027 patients with cervicitis related diseases.
12:406-412.
2012
-
Developing overall design, multi-sectoral joint medical safety and quality management systems: The experience and enlightenment from the medical risk management system of New South Wales Of Australia.
12:256-259.
2012
-
Evidence-based evaluation and selection of essential medicine for the pilot township health centers located in Eastern, Central and Western China, part I: Analysis on inpatient disease constitution in 8 pilot township health centers located in Eastern, Central and Western China in 2010.
12:260-266.
2012
-
Comparative analyses on methods and tools for medical risk management and assessment in the United Kingdom, the United States, Canada, Australia and Taiwan region.
11:1240-1246.
2011
-
Analyses on monitoring and countermeasures of Sichuan emergent public health events before and after Wenchuan earthquake.
11:885-892.
2011
-
Visualization studies on evidence-based medicine domain knowledge (series 3): Visualization for dissemination of evidence-based medicine information.
11:858-867.
2011
-
A study on risk evaluation indicator system and comprehensive evaluation method for intrauterine device.
11:753-762.
2011
-
Analyses of efficacy and safety of six injections containing Houttuynia cordata.
11:799-804.
2011
-
Efficacy of Houttuynia cordata Injection for respiratory system diseases: A meta-analysis.
11:786-798.
2011
-
Interferon-γ release assays screening for latent tuberculosis screening: A cost-effectiveness analysis.
11:768-774.
2011
-
Visualization studies on evidence-based medicine domain knowledge (series 2) -structural diagrams of author networks.
11:743-752.
2011
-
A comparative study on top 15 inpatient diseases in pilot township health centers in Western China from 2008 to 2010.
11:622-630.
2011
-
Visualization studies on evidence-based medicine domain knowledge (series 1): Mapping of evidence-based medicine research subjects.
11:613-621.
2011
-
A status survey on disease constitution and hospitalization cost in Yong'an Central Township Health Center, Shuangliu County of Sichuan Province from 2008 to 2010.
11:383-389.
2011
-
Descriptive analysis on ICU medical risk management in United Kingdom, United States, Australia, Canada and Taiwan.
11:357-366.
2011
-
International comparative analyses of incidents reporting systems for healthcare risk management.
11:237-246.
2011
-
A status survey on disease constitution and cost of inpatients in xintian central township health center in Lintao County of Gansu Province, 2008-2010.
11:131-137.
2011
-
Comparative analyses of institutions, regulations and administration on healthcare risk management in United Kingdom, United States, Canada, Australia and Taiwan district.
11:117-124.
2011
-
Regional economic levels and adverse events linked to intrauterine devices.
11:138-142.
2011
-
A satisfaction survey on students in evidence-based medical postgraduate summer school.
11:44-48.
2011
-
A status survey on disease constitution and cost of inpatients in Gaozha Central Township Health Center in Wuzhong City of Ningxia Hui Autonomous Region from 2008 to 2010.
11:20-28.
2011
-
GRADE guidelines: 6. Rating the quality of evidence-imprecision.
11:1435-1443.
2011
-
GRADE guidelines: 7. Rating the quality of evidence-inconsistency.
11:1444-1451.
2011
-
GRADE guidelines: 8. Rating the quality of evidence-Indirectness.
11:1452-1458.
2011
-
GRADE guidelines: 9. Rating up the quality of evidence.
11:1459-1463.
2011
-
GRADE guidelines: A new series of articles in the journal of clinical epidemiology.
11:1427-1429.
2011
-
A status survey on disease constitution and drug application of inpatients in yong'an central township health center in Shuangliu county of Sichuan province in 2009.
10:1381-1389.
2010
-
Using individual patients data in meta-analyses for assessing effects of health care interventions.
10:998-1003.
2010
-
Risk management experience for innovative drugs of FDA and MHRA derived from the marketing or withdrawal of natalizumab.
10:811-816.
2010
-
A cross-sectional investigation on mental situations of 225 parents of student victims in the Wenchuan earthquake.
10:653-657.
2010
-
Investigation on current situations of operation management and corporate culture in public hospital pharmacies.
10:458-462.
2010
-
Adverse drug reactions and adverse events of 33 varieties of traditional Chinese medicine injections on the national essential drugs list (2004 edition) of China: An overview on published literatures.
10:132-139.
2010
-
Adverse drug reactions of shuanghuanglian injection: A systematic review of public literatures.
10:140-147.
2010
-
The efficacy and safety of mirtazapine and fluoxetine for depression: A meta-analysis.
10:196-202.
2010
-
Investigation on the current situations of human resource management in public hospital pharmacies.
10:5-9.
2010
-
A comparative study between the newest essential medicine lists of China and the WHO in 2009.
9:1173-1184.
2009
-
Investigation on the current leadership situation in public hospital pharmacies.
9:1281-1284.
2009
-
Investigation on the current status of management and operation in public hospital pharmacies.
9:1155-1159.
2009
-
Risk monitoring of biologicals derived from adverse reaction management of natalizumab: A systematic review based on serious adverse reaction reports and related regulatory documents.
9:1185-1192.
2009
-
A comparative study among the essential medicine list, national insurance medicine list of China, and national essential medicine list of the WHO.
9:765-773.
2009
-
A systematic review of national drug policy in seventeen countries.
9:715-729.
2009
-
An investigation on the medicine supply chain in rural hospitals and community health service centers in Chengdu.
9:509-516.
2009
-
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.
9:503-508.
2009
-
Organ transplantation and brain death legislation in China: Strategies and thoughts.
9:400-407.
2009
-
Carnitine in the treatment of idiopathic asthenozoospermia: A systematic review.
9:337-345.
2009
-
Utilization analysis of drug efficacy of the 329 cases of wenchuan earthquake women and children patients.
9:265-272.
2009
-
GRADE: What is "Quality of evidence" and why is it important to clinicians?.
9:133-137.
2009
-
An investigation of common diseases and rational drug use in rural hospitals and community health service centers in Chengdu.
9:19-25.
2009
-
GRADE: An emerging consensus on rating quality of evidence and strength of recommendations.
9:8-11.
2009
-
Systematic review of economic analyses: Methods and challenges.
8:1007-1011.
2008
-
Investigation on the incidence of urolithiasis in infants fed by milk powder tainted with melamine in the middle area of Anhui province.
8:1039-1042.
2008
-
Contrastive analysis of the medical charity donations for the patients at home and abroad in West China Hospital.
8:769-772.
2008
-
A survey on the human resource allocation of chengdu rural/community health service organizations: A pre-survey report of three circles, seven rural hospitals/centers and six village health situations (Part).
8:420-428.
2008
-
An investigation of medicine use in rural hospitals and community health service centers in Chengdu.
8:529-537.
2008
-
Graft urethroplasty for urethral stricture: Ventral onlay versus dorsal onlay.
8:182-189.
2008
-
An investigation of basic health care service provided by rural hospitals and community health service centers in Chengdu.
8:226-232.
2008
-
Contraceptive effect and safety of ethinyl estradiol versus desogestrel: A systematic review.
8:252-260.
2008
-
Evolution of levels of evidence and strength of recommendations in medical research.
8:127-133.
2008
-
Effectiveness and safety of combination therapy of zidovudine and lamivudine for preventing the risk of mother-to-child transmission of HIV: A systematic review.
7:487-495.
2007
-
Medical expulsive therapy for ureteral calculi with tamsulosin: Evidence from A meta-analysis of randomized controlled trials.
7:506-515.
2007
-
Adjuvant effect of mycobacterium vaccae on treatment of recurrent treated pulmonary tuberculosis: A meta-analysis.
7:449-455.
2007
-
Can training courses improve medical postgraduates' knowledge, skill, attitude and behavior related to evidence-based medicine? A before-and-after study.
7:337-343.
2007
-
Effectiveness and safety of zidovudine for preventing the risk of mother-to-child transmission of HIV: A systematic review.
7:367-384.
2007
-
Effectiveness and safety of different injection sites of collagenase for lumbar intervertebral disc protrusion: A systematic review.
7:53-60.
2007
-
Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: A meta-analysis.
7:27-36.
2007
-
Collagenase for intervertebral disk hernia: A systematic review.
6:885-892.
2006
-
Evidence-based review on medical risk management in Canada - To provide evidence for establishing a medical risk precaution and monitoring system in China.
6:897-904.
2006
-
Doctors' perceptions of difficulties in patient involvement in making treatment decisions: Questionnaire study in China.
6:783-785.
2006
-
Evidence-based evaluation of a medical risk management system and preventative measures in New Zealand.
6:673-681.
2006
-
Evidence-based evaluation of medical risk management system in UK and its application to medical risk management in China.
6:514-522.
2006
-
Evidence-based evaluation of American medical risk monitoring and precaution system.
6:439-450.
2006
-
Safety and efficacy of steroid withdrawal in modern triple immunosuppressant: A systematic review.
6:273-281.
2006
-
Effectiveness and safety of rapamycin-based immunosuppression regimen with or without CsA in renal transplantation: A systematic review.
6:94-106.
2006
-
Comparative effectiveness of medicated γ-IUD (intrauterine device) with other IUDs for contraception: A systematic review.
6:30-46.
2006
-
A survey of evidence-based medicine teaching in China.
5:955-957.
2005
-
Evidence-based medicine in USA: Current application and practice.
5:487-488.
2005
-
Assessing the quality of reports of randomized trials in pediatric complementary and alternative medicine.
5:400-403.
2005
-
The effectiveness of tacrolimus and cyclosporine A after renal transplantation: A systematic review.
5.
2005
-
Evidence-based practitioners and evidence-based care.
5:99-100.
2005
-
Cost-effectiveness of treatment of chronic hepatitis B in China: A systematic review.
5:833-845.
2005
has subject area
Identity
International Standard Serial Number (ISSN)